Investor Presentaiton slide image

Investor Presentaiton

35 International Leading Capabilities on Manufacturing and Quality Management Xuhui Site 24,000L Songjiang 1st Plant 24,000L Songjiang 2nd Plant 36.0001 +60,000 Manufacturing capacity optimization: The scale of commercial GMP batches has reached a new high ⚫ "Henlius Quality" with international standard: obtained GMP certification from China, the EU and PIC/S members (Indonesia, Brazil) ⚫ Global expansion: Products available in Europe, Australia, South America and Southeast Asia Continuous Improvement Increasing supply of HANQUYOU (Trastuzumab): Over 100 batches in total, manufacturing successful rate > 98% Global GMP standards: completed Pre- License Inspections (PLI) by FDA Improving the laboratory infrastructure: Strengthen downstream and formulation process optimization and scale-up capabilities Aligned Quality & Efficiency O 2024 Henlius. Plant construction for Phase I & II trials: two main manufacturing buildings were completed and accepted; the engineering batch for the 2nd generation process of HANSIZHUANG has completed; PFS production line has been validated, ADC manufacturing workshop has put into use The improved application of stainless steel equipment: Costs reduction by process automation Intelligent Drug Manufacturing 2 Henlius
View entire presentation